The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 5, 2008, Pages

  Chapman, Martin D ^a   Ferreira, Fatima ^b   Villalba, Mayte ^c   Cromwell, Oliver ^d   Bryan, Donna ^e   Becker, Wolf Meinhard ^f   Fernández Rivas, Montserrat ^g   Durham, Stephen ^h   Vieths, Stefan ⁱ   van Ree, Ronald ^j  

^a INDOOR Biotechnologies Inc   (United States)

^b UNIVERSITY OF SALZBURG   (Austria)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f RESEARCH CENTER BORSTEL   (Germany)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ PAUL EHRLICH INSTITUT   (Germany)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

Allergen standardization; allergic diseases; allergy diagnostics; allergy vaccines; asthma; genetic engineering; IgE; immunotherapy; purified allergens

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; RECOMBINANT ALLERGEN; VACCINE;

ALLERGY; ANTIGEN BINDING; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTAMINE RELEASE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEDICAL SOCIETY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; STANDARDIZATION; X RAY CRYSTALLOGRAPHY;

EID: 55549137699     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.030     Document Type: Article

References (31)

1. Bousquet J., Lockey R., and Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102 (1998) 558-562
2. Nelson H.S. Allergen immunotherapy: where is it now?. J Allergy Clin Immunol 119 (2007) 769-779
3. van Ree R. Indoor allergens: relevance of major allergen measurements and standardization. J Allergy Clin Immunol 119 (2007) 270-277
4. Scheiner O., Breiteneder H., Dolocek C., Duchene M., Ebner C., Ferreira F., et al. Molecular and functional characterization of allergens: basic and practical aspects. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 87 (1994) 221-232
5. Chapman M.D., Smith A.M., Vailes L.D., Arruda L.K., Dhanaraj V., and Pomés A. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 106 (2000) 409-418
6. Becker W.M., Vogel L., and Vieths S. Standardization of allergen extracts for immunotherapy: where do we stand?. Curr Opin Allergy Clin Immunol 6 (2006) 470-475
7. Platts-Mills T.A., Vervloet D., Thomas W.R., Aalberse R.C., and Chapman M.D. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol 100 suppl (1997) S2-S24
8. Sporik R., Squillace S.P., Ingram J.M., Rakes G., Honsinger R.W., and Platts-Mills T.A. Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools. Thorax 54 (1999) 675-680
9. Arbes Jr. S.J., Cohn R.D., Yin M., Muilenberg M.L., Burge H.A., Friedman W., et al. House dust mite allergen in US beds: results from the First National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 111 (2003) 408-414
10. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003) 1414-1422
11. Woodcock A., Lowe L.A., Murray C.S., Simpson B.M., Pipis S.D., Kissen P., et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 170 (2004) 433-439
12. Zock J.P., Heinrich J., Jarvis D., Verlato G., Norback D., Plana E., et al. Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 118 (2006) 682-690
13. Heinrich J., Bedada G.B., Zock J.P., Chinn S., Norback D., Olivieri M., et al. Cat allergen level: its determinants and relationship to specific IgE to cat across European centers. J Allergy Clin Immunol 118 (2006) 674-681
14. Illi S., von M.E., Lau S., Niggemann B., Gruber C., and Wahn U. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 368 (2006) 763-770
15. Platts-Mills T.A., Vaughan J.W., Carter M.C., and Woodfolk J.A. The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol 106 (2000) 787-804
16. Morgan W.J., Crain E.F., Gruchalla R.S., O'Connor G.T., Kattan M., Evans III R., et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 351 (2004) 1068-1080
17. Platts-Mills T.A., and Chapman M.D. Allergen standardization. J Allergy Clin Immunol 87 (1991) 621-625
18. Bousquet J., Lockey R., Malling H.J., varez-Cuesta E., Canonica G.W., Chapman M.D., et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 81 (1998) 401-405
19. American Academy of Allergy Asthma and Immunology. Position Statement. The use of standardized allergen extracts. J Allergy Clin Immunol 99 (2007) 583-586
20. van Ree R. A new start for allergen references and standardization based on purified/recombinant allergens and monoclonal and monospecific polyclonal antibodies. In: Kurth R., and Haustein D. (Eds). Regulatory control and standardization of allergenic extracts (2007), GIT VERLAG GMBH, Darmstadt (Germany) 87-92
21. van Ree R., Chapman M.D., Ferreira F., Vieths S., Bryan D., Cromwell O., et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 63 (2008) 310-326
22. Reinders J., Lewandrowski U., Moebius J., Wagner Y., and Sickmann A. Challenges in mass spectrometry-based proteomics. Proteomics 4 (2004) 3686-3703
23. Geerlof A., Brown J., Coutard B., Egloff M.P., Enguita F.J., Fogg M.J., et al. The impact of protein characterization in structural proteomics. Acta Crystallogr D Biol Crystallogr 62 (2006) 1125-1136
24. Verdino P., and Keller W. Circular dichroism analysis of allergens. Methods 32 (2004) 241-248
25. Aalberse R.C., Koshte V., and Clemens J.G. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol 68 (1981) 356-364
26. Kleine B., I, de Heer P.G., van der Zee J.S., and Aalberse R.C. The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum. Int Arch Allergy Immunol 126 (2001) 277-285
27. Takai T., Kato T., Yasueda H., Okumura K., and Ogawa H. Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains. J Allergy Clin Immunol 115 (2005) 555-563
28. Jutel M., Jaeger L., Suck R., Meyer H., Fiebig H., and Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 116 (2005) 608-613
29. Suck R., Kamionka T., Schaffer B., Wahl R., Nandy A., Weber B., et al. Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1. Biochim Biophys Acta 1764 (2006) 1701-1709
30. Chapman M.D., Pomés A., Breiteneder H., and Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol 119 (2007) 414-420
31. Batard T., Didierlaurent A., Chabre H., Mothes N., Bussieres L., Bohle B., et al. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int Arch Allergy Immunol 136 (2005) 239-249